Udodirim N Onwubiko
Overview
Explore the profile of Udodirim N Onwubiko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onwubiko U, Murray S, Rao A, Chamberlain A, Sanchez T, Benkeser D, et al.
Soc Sci Med
. 2024 Nov;
363:117493.
PMID: 39541830
Background: Sexual stigma, mental health disorders, and socioeconomic disparities present important yet incompletely understood barriers to PrEP adoption among gay men and other men who have sex with men (MSM)....
2.
Onwubiko U, Mehta C, Wiley Z, Jacob J, Ashley Jones K, Kubes J, et al.
Antimicrob Steward Healthc Epidemiol
. 2024 Oct;
4(1):e163.
PMID: 39411663
Background: Among inpatients, peer-comparison of prescribing metrics is challenging due to variation in patient-mix and prescribing by multiple providers daily. We established risk-adjusted provider-specific antibiotic prescribing metrics to allow peer-comparisons...
3.
Ackleh-Tingle J, Jordan N, Onwubiko U, Chandra C, Harton P, Rentmeester S, et al.
JMIR Form Res
. 2022 Nov;
6(11):e38425.
PMID: 36343211
Background: Primary care providers are regarded as trustworthy sources of information about COVID-19 vaccines. Although primary care practices often provide information about common medical and public health topics on their...
4.
Ashley Jones K, Onwubiko U, Kubes J, Albrecht B, Paciullo K, Howard-Anderson J, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Sep;
1(1):e32.
PMID: 36168449
Objective: To determine the impact of an inpatient stewardship intervention targeting fluoroquinolone use on inpatient and postdischarge infection (CDI). Design: We used an interrupted time series study design to evaluate...
5.
Fridkin S, Onwubiko U, Dube W, Robichaux C, Traenkner J, Goodenough D, et al.
Infect Control Hosp Epidemiol
. 2022 Sep;
44(7):1085-1092.
PMID: 36102331
Objective: We evaluated the impact of test-order frequency per diarrheal episodes on difficile infection (CDI) incidence estimates in a sample of hospitals at 2 CDC Emerging Infections Program (EIP) sites....
6.
Onwubiko U, Yoon J, Ajoku S, Khan A, Holland D
Am J Public Health
. 2022 Apr;
112(6):881-885.
PMID: 35420895
People experiencing homelessness are at increased risk of tuberculosis (TB) and HIV. We examined the impact of integrating HIV testing and mandatory TB screening on HIV test uptake (HTU) during...
7.
Garlow E, Onwubiko U, Holland D, Chamberlain A
J Behav Med
. 2022 Apr;
45(3):428-437.
PMID: 35394241
Healthcare providers whom people see regularly (e.g., primary care providers [PCPs]) are likely to interact with individuals at risk of human immunodeficiency virus (HIV). However, most PCPs report never prescribing...
8.
Chishinga N, Smith S, Gandhi N, Onwubiko U, Telford C, Prieto J, et al.
Open Forum Infect Dis
. 2022 Apr;
9(4):ofac101.
PMID: 35360195
Background: We examined differences in mortality among coronavirus disease 2019 (COVID-19) cases in the first, second, and third waves of the COVID-19 pandemic. Methods: A retrospective cohort study of COVID-19...
9.
Chishinga N, Gandhi N, Onwubiko U, Telford C, Prieto J, Smith S, et al.
medRxiv
. 2020 Dec;
PMID: 33354690
Background: We present data on risk factors for severe outcomes among patients with coronavirus disease 2019 (COVID-19) in the southeast United States (U.S.). Objective: To determine risk factors associated with...
10.